Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ranibizumab in Exudative AMD (RESPONSE)
NCT01213667Phase 4Unknown
- Sponsor
- University of Cologne
- Start
- Jan 2010
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in exudative age-related macular degeneration, sponsored by University of Cologne. Status: unknown.
02
Drugs
ranibizumab
03
Conditions
exudative age-related macular degeneration
Beyond the preview
Go deeper on NCT01213667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01213667.